Results of CHOP chemotherapy for diffuse large B-cell lymphoma

Autor: A.E. Hallack Neto, J. Pereira, B. Beitler, D.A.F. Chamone, P.D. Llacer, F.L. Dulley, M.C.M.A. Macedo, A. Chaoubah

Publikováno v: Brazilian Journal of Medical and Biological Research, Vol 39, Iss 10, Pp 1315-1322 (2006)

Patients with diffuse large B-cell lymphoma treated in a University Hospital were studied from 1990 to 2001. Two treatment regimens were used: ProMACE-CytaBOM and then, from November 1996 on, the CHOP regimen. Complete remission (CR), disease-free su

Externí odkaz: https://doaj.org/article/c011c811540449859dc61457bcf33bbb

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide

Autor: Angelo Atalla, A.E. Hallack Neto, Luiz Cláudio Ribeiro, T.B.M. Castro

Publikováno v: Brazilian Journal of Medical and Biological Research, Vol 49, Iss 6 (2016)
Brazilian Journal of Medical and Biological Research, Volume: 49, Issue: 6, Article number: e5128, Published: 31 MAY 2016
Brazilian Journal of Medical and Biological Research
Brazilian Journal of Medical and Biological Research v.49 n.6 2016
Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC

In order to evaluate the main adverse effects of drug protocols using bortezomib and/or thalidomide for the treatment of multiple myeloma, we conducted a prospective study. Data were collected through interviews, clinical observation, and from hospit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::612b2032fc4017bda839cc16de17e4b8
http://www.scielo.br/pdf/bjmbr/v49n6/1414-431X-bjmbr-1414-431X20165128.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.